Moatly / Stocks / JNJ

Johnson & Johnson (JNJ) — what is it worth?

$280.78 · $675.9B market cap · Drug Manufacturers - General
Scored from reported financial statements. Data as of 2026-11-11.
Moat
53
Durability of advantage
Management
99
Returns and capital use
Margin of safety
3
Price against value
Buy price
$90.91
Consensus of three methods
Intrinsic value
$16.97
What the business is worth
Margin of safety price
$8.48
Intrinsic value less 50%
10-CAP price
$90.91
Ten times owner earnings
Payback time price
$82.02
Eight years of free cash flow
Moatly AI Insight

Johnson & Johnson scores 99 for management and 53 for moat. The management score rests on a return on invested capital of 13.7% and a gross margin of 67.9% — figures that describe a business turning capital into profit efficiently. Debt sits at 0.59x equity. The moderate moat and exceptional management are not the same judgement, and the gap between them is where the argument about this business sits.

The valuation runs on assumptions chosen to understate rather than flatter. Growth is modelled at 2.7% a year, below the 3.0% actually measured over the last decade — the model caps growth rather than extrapolating a good run forwards. The exit multiple assumed is 8.0x. That produces an intrinsic value of $16.97, a 10-CAP price of $90.91 and a payback time price of $82.02, with the value zone set at the highest of the three, $90.91. Today's price of $280.78 is 209% above it.

The operating figures describe a business performing at a high level; the price asks for that performance to continue and then some. A margin of safety score of 3 is the measure of how little room that leaves for being wrong.

Key figures

Price$280.78
Market cap$675.9B
P/E ratio42.6x
Return on invested capital13.7%
Gross margin67.9%
Debt to equity0.59x
Free cash flow yield3.9%
Growth rate used2.7%
Growth rate measured3.0%
Exit multiple assumed8.0x

How it compares

CompanyMoatBuy price
AbbVie Inc. (ABBV)22$113.65
Roche Holding AG (RHHBY)21$60.56
Merck & Co. Inc. (MRK)56$78.55
Astrazeneca Plc (AZN)95$106.50

Be in the know

Subscribe to our Substack for deeper insights on value plays.

Subscribe free

Run your own assumptions

Every number above is built on assumptions that can be changed. In Moatly you can move the growth rate, the exit multiple and the margin of safety and watch every figure recalculate, so you are testing your own view of Johnson & Johnson rather than accepting ours.

Download on the App StoreGet it on Google Play

Not investment advice. Estimates only, built on stated assumptions that could be wrong. Figures are drawn from reported financial statements and were current as of the date shown. Do your own research.